Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Svp, Chief Financial Officer
-
Stock Symbol
-
HALO on Nasdaq
Nicole LaBrosse - trading volume in the past year for Halozyme Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
28.8K |
$1.68M |
$58.29 |
Feb 16, 2025 |
Direct |
|
|
Restricted Stock Units |
10.7K |
$621K |
$58.29 |
Feb 16, 2025 |
Direct |
Common Stock |
|
Performance Stock Unit |
6.94K |
$391K |
$56.41 |
Feb 12, 2025 |
Direct |
Common Stock |
|
Option to Purchase Common Stock |
5K |
$69.4K |
$13.87 |
Jun 28, 2024 |
Direct |
Common Stock |
|
Performance Stock Units |
0 |
$0 |
$58.29 |
Feb 16, 2025 |
Direct |
Common Stock |
|
Option to Purchase Common Stock |
0 |
|
|
Jul 22, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.